Hanmi Pharm diversifies volumes and dosage forms of Korean influenza drug ‘Hanmi Fly’

So far, Hanmi Pharm has localized influenza treatments in Korea which had depended on foreign ones, and diversified their volumes and dosage forms.

On the 14^th, Hanmi Pharm(CEO Kwan-Soon Lee) announced it recently acquired additional approvals of Hanmi Flu Cap 60mg and Hanmi Flu Solution 50mL.

Thus, Hanmi Pharm now owns 4 products of Hanmi Flu Cap with 30mg, 45mg, 60mg and 75mg and 2 products...